Wilson, Travis M.
Munaf, Uzair
Shaikh, Nafhat
Rizwan, Affan
Siddiqui, Riyan
Virk, Hafeez Ul Hassan
Alam, Mahboob
Khalid, Umair
Khawaja, Muzamil
Attachaipanich, Tanawat
Cavallari, Larisa H.
Ahuja, Tania
Nanna, Michael G.
Sharma, Samin K.
Klein, Lloyd W.
Mintz, Gary S.
Krittanawong, Chayakrit
Article History
Received: 28 May 2025
Accepted: 24 February 2026
First Online: 23 March 2026
Competing interests
: Dr. Krittanawong is the founder of HumanX, a company that focuses on artificial intelligence in precision medicine and innovation in healthcare; he declares that his affiliation with HumanX is not a competing interest. Dr. Nanna reports unrelated research funding from the American College of Cardiology (George F and Ann Harris Bellows Foundation), the Patient-Centered Outcomes Research Institute, the Yale Claude D. Pepper Older Americans Independence Center (P30AG021342), and the National Institute on Aging/National Institutes of Health (K76AG088428). Dr. Nanna also reports personal fees from HeartFlow, Novo Nordisk, and Merck. The remaining authors declare no competing interests.